“Red Hand Syndrome” Due to Cytarabine in a Case of Mantle Cell Lymphoma
Images
First Online:
Received:
Accepted:
- 62 Downloads
- 1 Citations
Keywords
Cytarabine Mantle Cell Lymphoma Acute Myelogenous Leukemia Skin Toxicity Cutaneous Toxicity
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Notes
Compliance with Ethical Standards
Conflicts of interests
The authors Ankur Jain, Pankaj Malhotra, Gaurav Prakash and Subhash Varma disclose no conflicts of the interests.
Informed Consent
Informed consent was obtained from the patient prior to submission of the paper.
References
- 1.Skarbnik AP, Goy AH (2015) Mantle cell lymphoma: state of the art. Clin Adv Hematol Oncol 13:44–55PubMedGoogle Scholar
- 2.Burgdorf WH, Gilmore WA, Ganick RG (1982) Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia. Ann Intern Med 97:61–62CrossRefPubMedGoogle Scholar
- 3.Webster-Gandy JD, How C, Harrold K (2007) Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer center. Eur J Oncol Nurs 11:238–246CrossRefPubMedGoogle Scholar
- 4.Cetkovska P, Pizinger K, Cetkovsky P (2002) High-dose cytosine arabinoside-induced cutaneous reactions. J Eur Acad Dermatol Venereol 16:481–485CrossRefPubMedGoogle Scholar
- 5.Morio K, Mizuki M, Sozu T, Uejima E (2014) Risk factors for cytarabine-induced cutaneous toxicity in patients with haematological malignancies. Chemotherapy 60:168–173CrossRefPubMedGoogle Scholar
Copyright information
© Indian Society of Haematology & Transfusion Medicine 2016